1,4-Benzodioxin-6-carboxamide, 2-[(1E)-1-(aminomethyl)-2-fluoroethenyl]-N-(1,1-dimethylethyl)-2,3-dihydro-, hydrochloride (1:1)

Request For Quotation
1,4-Benzodioxin-6-carboxamide, 2-[(1E)-1-(aminomethyl)-2-fluoroethenyl]-N-(1,1-dimethylethyl)-2,3-dihydro-, hydrochloride (1:1) Suppliers list
Company Name: Shandong Dayou Pharmaceutical Research and Development Co., Ltd.  
Tel: hanfangpharma@126.com 15165037910
Email: hanfangpharma@126.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Company Name: TargetMol Chemicals Inc.  
Tel: 13564774135
Email: marketing@targetmol.com

1,4-Benzodioxin-6-carboxamide, 2-[(1E)-1-(aminomethyl)-2-fluoroethenyl]-N-(1,1-dimethylethyl)-2,3-dihydro-, hydrochloride (1:1) manufacturers
1,4-Benzodioxin-6-carboxamide, 2-[(1E)-1-(aminomethyl)-2-fluoroethenyl]-N-(1,1-dimethylethyl)-2,3-dihydro-, hydrochloride (1:1) Basic information
Product Name:1,4-Benzodioxin-6-carboxamide, 2-[(1E)-1-(aminomethyl)-2-fluoroethenyl]-N-(1,1-dimethylethyl)-2,3-dihydro-, hydrochloride (1:1)
Synonyms:1,4-Benzodioxin-6-carboxamide, 2-[(1E)-1-(aminomethyl)-2-fluoroethenyl]-N-(1,1-dimethylethyl)-2,3-dihydro-, hydrochloride (1:1);SSAO/VAP-1 inhibitor 1
CAS:2647975-06-0
MF:C16H22ClFN2O3
MW:344.81
EINECS:
Product Categories:
Mol File:2647975-06-0.mol
1,4-Benzodioxin-6-carboxamide, 2-[(1E)-1-(aminomethyl)-2-fluoroethenyl]-N-(1,1-dimethylethyl)-2,3-dihydro-, hydrochloride (1:1) Structure
1,4-Benzodioxin-6-carboxamide, 2-[(1E)-1-(aminomethyl)-2-fluoroethenyl]-N-(1,1-dimethylethyl)-2,3-dihydro-, hydrochloride (1:1) Chemical Properties
Safety Information
MSDS Information
1,4-Benzodioxin-6-carboxamide, 2-[(1E)-1-(aminomethyl)-2-fluoroethenyl]-N-(1,1-dimethylethyl)-2,3-dihydro-, hydrochloride (1:1) Usage And Synthesis
UsesSSAO/VAP-1 inhibitor 1 is a potent inhibitor of SSAO/VAP-1. SSAO/VAP-1 promotes the transfer of Glucose transport 4 (GLUT 4) from adipocytes to the cell membrane, thereby regulating glucose transport. In endothelial cells, SSAO/VAP-1 can mediate the adhesion and exudation of leukocytes and endothelial cells, and participate in inflammatory responses. SSAO/VAP-1 inhibitor 1 has the potential for the research of inflammation and/or inflammation-related disease or diabetes and/or diabetes-related disease (extracted from patent WO2021102774A1, compound E3)[1].
References[1] Zhen Gu, et al. A kind of amine derivative as ssao/vap-1 inhibitor and use thereof. Patent WO2021102774A1.
1,4-Benzodioxin-6-carboxamide, 2-[(1E)-1-(aminomethyl)-2-fluoroethenyl]-N-(1,1-dimethylethyl)-2,3-dihydro-, hydrochloride (1:1) Preparation Products And Raw materials
Tag:1,4-Benzodioxin-6-carboxamide, 2-[(1E)-1-(aminomethyl)-2-fluoroethenyl]-N-(1,1-dimethylethyl)-2,3-dihydro-, hydrochloride (1:1)(2647975-06-0) Related Product Information
4-Piperidinol, 1-[5-[[(2E)-2-(aminomethyl)-3-fluoro-2-propen-1-yl]oxy]-2-pyrimidinyl]-4-methyl- PXS-4681A Vapaliximab NA Benzamide, 4-[[(2E)-2-(aminomethyl)-3-fluoro-2-propen-1-yl]oxy]-N-(1,1-dimethylethyl)- Timolumab